A5051028188- Breast Lesions and Carcinomas
- Ovarian cancer diagnosis and treatment
- Breast Cancer Treatment Studies
- MRI in cancer diagnosis
- Endometrial and Cervical Cancer Treatments
- Radiomics and Machine Learning in Medical Imaging
- Cancer and Skin Lesions
- Intraperitoneal and Appendiceal Malignancies
- Endometriosis Research and Treatment
- Cancer Diagnosis and Treatment
- Urinary and Genital Oncology Studies
- Diverticular Disease and Complications
- Digital Radiography and Breast Imaging
- Medical Imaging Techniques and Applications
- AI in cancer detection
- Radiation Dose and Imaging
- Cancer Genomics and Diagnostics
- Global Cancer Incidence and Screening
- Advanced MRI Techniques and Applications
- Cerebrovascular and Carotid Artery Diseases
- HER2/EGFR in Cancer Research
- Diagnosis and treatment of tuberculosis
- Fetal and Pediatric Neurological Disorders
- Ultrasound and Hyperthermia Applications
- Abdominal vascular conditions and treatments
Institut Paoli-Calmettes
2013-2024
Aix-Marseille Université
2016-2024
Inserm
2022
Centre de Recherche en Cancérologie de Marseille
2022
Centre National de la Recherche Scientifique
2022
Institut Pprime
2011-2019
Sorbonne Université
2010-2014
Hôpital Tenon
2010-2014
Université Paris Cité
2011
Approximately one-quarter of adnexal masses detected at ultrasonography are indeterminate for benignity or malignancy, posing a substantial clinical dilemma.To validate the accuracy 5-point Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) score risk stratification masses.This multicenter cohort study was conducted between March 1, 2013, and 31, 2016. Among patients undergoing expectant management, 2-year follow-up data were completed by 2018. A routine pelvic MRI...
Purpose To construct and undertake preliminary validation of a magnetic resonance (MR) imaging scoring system designed for use in pelvic MR performed characterization adnexal masses that were indeterminate at ultrasonography (US). Materials Methods The institutional ethics committee approved this retrospective study granted waiver informed consent. population comprised 394 women who underwent between January 1, 2008, October 30, 2010, 497 seen US. Then, chronologically divided into training...
Background The MRI Ovarian-Adnexal Reporting and Data System (O-RADS) enables risk stratification of sonographically indeterminate adnexal lesions, partly based on time-intensity curve (TIC) analysis, which may not be universally available. Purpose To compare the diagnostic accuracy visual assessment with that TIC dynamic contrast-enhanced scans to categorize lesions as benign or malignant evaluate influence O-RADS score. Materials Methods European Adnex MR Study Group, EURAD, database, a...
In 2021, the American College of Radiology (ACR) Ovarian-Adnexal Reporting and Data System (O-RADS) MRI Committee developed a risk stratification system lexicon for assessing adnexal lesions using MRI. Like BI-RADS classification, O-RADS provides standardized language communication between radiologists clinicians. It is essential to be familiar with algorithmic approach avoid misclassifications. Training, like that offered by International Ovarian Tumor Analysis (IOTA), ensure accurate...
Abstract Eighteen to 35% of adnexal masses remain non-classified following ultrasonography, leading unnecessary surgeries and inappropriate management. This finding led the conclusion that ultrasonography was insufficient accurately assess a standardized MRI criteria could improve these patients’ The aim this work is present different steps from identification clinical issue daily use score its inclusion in latest international guidelines. were following: (1) preliminary formalize issue, (2)...
Contribution of FDG PET/CT for the Optimization Management Additional Lesions Detected on Local Staging Breast MRIAurélie Jalaguier-Coudray1, Béatrice Delarbre1, Isabelle Brenot-Rossi2, Gilles Houvenaeghel3,4, Rim Villard-Mahjoub1, Patrice Viens4,5 and Thomassin-Naggara6,7Audio Available | Share Claim CREDIT
We examined characteristics trends in early breast cancer patients receiving neoadjuvant chemotherapy (NAC) over a 16-year period. Our primary objective was to analyze variations tumor stage and subtype time. Secondary objectives included analyses of type surgery pathological response, from January 2005 May 2021, 1623 NAC were identified. Three periods determined: 2005-2009 (P1), 2010-2014 (P2), 2015-2021 (P3). Correlations between patient features with cT stage, axillary node complete...